Related Experiment Video
Updated: May 8, 2026
09:31
Characterization of Amyloid Structures in Aging C. Elegans Using Fluorescence Lifetime Imaging
Published on: March 27, 2020
A dramatic increase of C1q protein in the CNS during normal aging
Alexander H Stephan1, Daniel V Madison, José María Mateos
1Stanford University School of Medicine, Department of Neurobiology, Stanford, California 94305-5345, USA. astephan@stanford.edu
Summary
Increased C1q protein in aging brains contributes to cognitive decline. C1q-deficient mice showed preserved cognitive function and synaptic plasticity, suggesting a novel role beyond complement pathways.
Area of Science:
- Neuroscience
- Immunology
- Aging Research
Background:
- Age-related cognitive decline impacts neuronal circuitry, with underlying molecular mechanisms unclear.
- C1q initiates complement cascade and mediates synapse elimination in the developing central nervous system (CNS).
Purpose of the Study:
- To investigate the role of C1q in the aging brain and its impact on cognitive function.
- To determine if elevated C1q in aging is linked to neurodegeneration and cognitive decline.
Main Methods:
- Quantified C1q protein levels in aging mouse and human brains using immunohistochemistry.
- Studied C1q-deficient mice to assess synaptic plasticity, brain circuitry, and cognitive performance in aging.
- Examined the involvement of complement component 3 (C3) in C1q's aging-dependent effects.
Main Results:
- C1q protein levels increased up to 300-fold in aging mouse and human brains, particularly near synapses in vulnerable regions like the hippocampus.
- C1q-deficient mice demonstrated enhanced synaptic plasticity and reduced cognitive/memory decline compared to wild-type littermates.
- The aging-related effects of C1q on hippocampal circuitry were independent of C3 and did not involve synapse loss.
Conclusions:
- Elevated C1q in the aging brain is associated with cognitive decline and impacts hippocampal circuitry.
- C1q plays a novel role in CNS aging that is independent of complement activation and synapse elimination.
- Targeting C1q may offer a new therapeutic strategy for age-related cognitive impairment.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...